Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (929)
All Articles published online
|
Feb 6, 2014 (publication date) through Jul 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hematology
ISSN
2218-6204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Afrin LB, Molderings GJ. A concise, practical guide to diagnostic assessment for mast cell activation disease. World J Hematol 2014; 3(1): 1-17 [DOI: 10.5315/wjh.v3.i1] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6204/full/v3/i1/1.htm |
| Number | Citing Articles |
| 1 |
Suranjith L. Seneviratne, Anne Maitland, Lawrence Afrin. Mast cell disorders in Ehlers–Danlos syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 2017; 175(1): 226 doi: 10.1002/ajmg.c.31555
|
| 2 |
Milda Vysniauskaite, Hans-Jörg Hertfelder, Johannes Oldenburg, Peter Dreßen, Stefan Brettner, Jürgen Homann, Gerhard J. Molderings, Kottarappat N Dileepan. Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease. PLOS ONE 2015; 10(4): e0124912 doi: 10.1371/journal.pone.0124912
|
| 3 |
Lawrence B. Afrin, Sally Self, Jeremiah Menk, John Lazarchick. Characterization of Mast Cell Activation Syndrome. The American Journal of the Medical Sciences 2017; 353(3): 207 doi: 10.1016/j.amjms.2016.12.013
|
| 4 |
B. Sido, J. Homann, H.-J. Hertfelder, T. Zienkiewicz, K.-P. Christians, P. Schablin, M. Mücke, G. J. Molderings. Chirurgische Eingriffe bei Patienten mit systemischer Mastzellaktivierungserkrankung. Der Chirurg 2019; 90(7): 548 doi: 10.1007/s00104-019-0935-z
|
| 5 |
Betsy Selleck, Cynthia Selleck. A Primer on Mast Cell Activation Disease for the Nurse Practitioner. The Journal for Nurse Practitioners 2021; 17(7): 776 doi: 10.1016/j.nurpra.2021.04.015
|
| 6 |
Karina Sturm, Helena Jung, Andrea Maier. Ratgeber Ehlers-Danlos-Syndrome. 2022; : 53 doi: 10.1007/978-3-662-65041-7_3
|
| 7 |
Gerhard J. Molderings, Britta Haenisch, Stefan Brettner, Jürgen Homann, Markus Menzen, Franz Ludwig Dumoulin, Jens Panse, Joseph Butterfield, Lawrence B. Afrin. Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(7): 671 doi: 10.1007/s00210-016-1247-1
|
| 8 |
Gerhard J. Molderings. The genetic basis of mast cell activation disease - looking through a glass darkly. Critical Reviews in Oncology/Hematology 2015; 93(2): 75 doi: 10.1016/j.critrevonc.2014.09.001
|
| 9 |
Lawrence B. Afrin, Alexander Khoruts. Mast Cell Activation Disease and Microbiotic Interactions. Clinical Therapeutics 2015; 37(5): 941 doi: 10.1016/j.clinthera.2015.02.008
|
| 10 |
Soumya Arun, Abbie Storan, Bethan Myers. Mast cell activation syndrome and the link with long COVID. British Journal of Hospital Medicine 2022; 83(7): 1 doi: 10.12968/hmed.2022.0123
|
| 11 |
Raymond F. Palmer, Tania T. Dempsey, Lawrence B. Afrin. Chemical Intolerance and Mast Cell Activation: A Suspicious Synchronicity. Journal of Xenobiotics 2023; 13(4): 704 doi: 10.3390/jox13040045
|
| 12 |
Craig Friesen, Meenal Singh, Vivekanand Singh, Jennifer V. Schurman. An observational study of headaches in children and adolescents with functional abdominal pain. Medicine 2018; 97(30): e11395 doi: 10.1097/MD.0000000000011395
|
| 13 |
Lawrence B. Afrin, Joseph H. Butterfield, Martin Raithel, Gerhard J. Molderings. Often seen, rarely recognized: mast cell activation disease – a guide to diagnosis and therapeutic options. Annals of Medicine 2016; 48(3): 190 doi: 10.3109/07853890.2016.1161231
|
| 14 |
Lawrence B. Afrin, Tania T. Dempsey, Leonard B. Weinstock. Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?. Vaccines 2022; 10(1): 127 doi: 10.3390/vaccines10010127
|
| 15 |
Lawrence B. Afrin. Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease. The American Journal of the Medical Sciences 2014; 348(6): 460 doi: 10.1097/MAJ.0000000000000325
|
| 16 |
Theoharis C. Theoharides, Irene Tsilioni, Huali Ren. Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?. Expert Review of Clinical Immunology 2019; 15(6): 639 doi: 10.1080/1744666X.2019.1596800
|
| 17 |
Visha Tailor, Vik Khullar. Postural Tachycardia Syndrome. 2021; : 125 doi: 10.1007/978-3-030-54165-1_17
|
| 18 |
Shanda R. Dorff, Lawrence B. Afrin. Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review. Journal of Obstetrics and Gynaecology 2020; 40(7): 889 doi: 10.1080/01443615.2019.1674259
|
| 19 |
Anupam Aich, Lawrence Afrin, Kalpna Gupta. Mast Cell-Mediated Mechanisms of Nociception. International Journal of Molecular Sciences 2015; 16(12): 29069 doi: 10.3390/ijms161226151
|
| 20 |
Susan J. Allen, Paul L. Chazot, C. Jane Dixon. Can H2‐receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19‐year‐old female? A case report. British Journal of Clinical Pharmacology 2018; 84(7): 1611 doi: 10.1111/bcp.13578
|
| 21 |
Peter C. Rowe. Principles and Practice of Pediatric Infectious Diseases. 2023; : 1056 doi: 10.1016/B978-0-323-75608-2.00200-7
|
| 22 |
Visha K. Tailor, Ellen Morris, Alka A. Bhide, Ruwan Fernando, Guiseppe A. Digesu, Vik Khullar. Does cystoscopy method affect the investigation of bladder pain syndrome/interstitial cystitis?. International Urogynecology Journal 2021; 32(5): 1229 doi: 10.1007/s00192-020-04512-0
|
| 23 |
Lawrence B. Afrin, Dieter Pöhlau, Martin Raithel, Britta Haenisch, Franz L. Dumoulin, Juergen Homann, Uwe M. Mauer, Sabrina Harzer, Gerhard J. Molderings. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain, Behavior, and Immunity 2015; 50: 314 doi: 10.1016/j.bbi.2015.07.002
|
| 24 |
Visha Tailor, Vik Khullar. Postural Tachycardia Syndrome. 2021; : 141 doi: 10.1007/978-3-030-54165-1_18
|
| 25 |
Lawrence B. Afrin, Tania T. Dempsey, Lila S. Rosenthal, Shanda R. Dorff. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding. Journal of Obstetrics and Gynaecology 2019; 39(5): 664 doi: 10.1080/01443615.2018.1550475
|
| 26 |
Lawrence B. Afrin. Mast cell activation disease and the modern epidemic of chronic inflammatory disease. Translational Research 2016; 174: 33 doi: 10.1016/j.trsl.2016.01.003
|
| 27 |
G. Simpson. Menstrual anaphylactoid reactions and presumed systemic mast cell activation syndrome. Internal Medicine Journal 2016; 46(7): 858 doi: 10.1111/imj.13077
|
| 28 |
Lawrence B. Afrin, Leonard B. Weinstock, Gerhard J. Molderings. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. International Journal of Infectious Diseases 2020; 100: 327 doi: 10.1016/j.ijid.2020.09.016
|
| 29 |
Tinus Häder, Gerhard J. Molderings, Frank Klawonn, Rupert Conrad, Martin Mücke, Julia Sellin. Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold. Digestive Diseases and Sciences 2023; 68(8): 3400 doi: 10.1007/s10620-023-07921-5
|
| 30 |
Nevio Cimolai. Mast Cell Biology and Linkages for Non-clonal Mast Cell Activation and Autoimmune/Inflammatory Syndrome Induced by Adjuvants. SN Comprehensive Clinical Medicine 2020; 2(11): 2310 doi: 10.1007/s42399-020-00494-8
|
| 31 |
Lawrence B. Afrin, Mary B. Ackerley, Linda S. Bluestein, Joseph H. Brewer, Jill B. Brook, Ariana D. Buchanan, Jill R. Cuni, William P. Davey, Tania T. Dempsey, Shanda R. Dorff, Martin S. Dubravec, Alena G. Guggenheim, Kimberly J. Hindman, Bruce Hoffman, David L. Kaufman, Stephanie J. Kratzer, Theodore M. Lee, Mindy S. Marantz, Andrew J. Maxwell, Kelly K. McCann, Dwight L. McKee, Laurie Menk Otto, Laura A. Pace, Dahra D. Perkins, Laurie Radovsky, Mary S. Raleigh, Sonia A. Rapaport, Emma J. Reinhold, Mark L. Renneker, William A. Robinson, Aaron M. Roland, E. Scott Rosenbloom, Peter C. Rowe, Ilene S. Ruhoy, David S. Saperstein, David A. Schlosser, Jill R. Schofield, Janet E. Settle, Leonard B. Weinstock, Martina Wengenroth, Mark Westaway, Shijun Cindy Xi, Gerhard J. Molderings. Diagnosis of mast cell activation syndrome: a global “consensus-2”. Diagnosis 2021; 8(2): 137 doi: 10.1515/dx-2020-0005
|
| 32 |
Gerhard J. Molderings. Transgenerational transmission of systemic mast cell activation disease—genetic and epigenetic features. Translational Research 2016; 174: 86 doi: 10.1016/j.trsl.2016.01.001
|